The departure of Amarin’s top executive comes as the New Jersey-based pharma company dealt with Sarissa, its largest shareholder, in a public war of words.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,